Researchers
from Washington University School of Medicine in St. Louis have shown
that nanoparticles infused with a toxic bee venom can kill HIV. The
researchers hope to take this new compound and develop a vaginal gel
that can prevent the further spread of the disease.
The
key to this discovery, which was made by Samuel A. Wickline and his
team at Washington University, involves cytolyic melittin peptides.
Melittin is found in bee venom, and it has the fortuitous trait of being
able to degrade the protective envelope that surrounds HIV.
For
the experiment, Wickline’s team prepared free melittin and
melittin-loaded nanoparticles and set them against various strains of
HIV (CXCR4 and CCR5 in particular). The researchers then showed that
melittin, when delivered in these large and free accumulations, can make
life miserable for the disease.
Moreover,
these melittin-loaded nanoparticles left the surrounding cells
unharmed, which bodes well for the development of a topical vaginal
virucide. But this didn’t happen by accident. The nanoparticles were
endowed with a kind of filter that prevents healthy cells from coming
into contact with the toxin. HIV, on the other hand, is small and it
sifts through these filters, thus exposing it to the toxin.
Unlike
other approaches, which work to prevent HIV from replicating,
Wickline’s technique involves the degradation of the virus’s structure.
“We
are attacking an inherent physical property of HIV,” said Joshua L.
Hood through a university statement, and a co-author of the study.
“Theoretically, there isn’t any way for the virus to adapt to that. The
virus has to have a protective coat, a double-layered membrane that
covers the virus.”
Interestingly,
the concept behind the melittin nanoparticle approach could conceivably
work against other diseases, including hepatitis B and C.
Eventually,
the topical gel could be combined with a spermicidal contraceptive and
act as a kind of two-in-one double-whammy. But for now, the researchers
say that the nanoparticles are safe for sperm, and will initially be
intended for couples who are trying to conceive.
And
as for the study itself, it’s the first proof-of-concept that the
therapeutic and safe application of a nanoparticle-mediated compound can
combat HIV-1.
Source: Washington University.
No comments:
Post a Comment